openPR Logo
Press release

Dermatomyositis Drug Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027

03-10-2022 11:26 AM CET | Health & Medicine

Press release from: Orion Market Research

The global dermatomyositis drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Dermatomyositis is a rare disease that is used to describe muscle and skin symptoms. It causes muscle inflammation and skin rash. Additionally, it causes muscle inflammation and swelling and is different from other muscle diseases as it also causes skin problems. The major factor driving the demand for dermatomyositis drug is the increasing prevalence of dermatomyositis disease across the globe.

According to the National Organization for Rare Diseases, dermatomyositis most commonly occurs between ages 40 to 60, however, it can occur in people of all ages or at any time from infancy through approximately age 80. Additionally, its prevalence is estimated at 9.63 cases per million people. Furthermore, its symptoms usually appear between the ages of 5 to 15 years in children. Moreover, an estimated 3 in 1,000,000 children are affected by juvenile dermatomyositis. Apart from this, females are affected twice as often as males by this disease. Hence, the increasing prevalence of dermatomyositis is driving the demand for dermatomyositis drugs for treatment which in turn is driving the growth of the market.

To Request a Sample of our Report on Dermatomyositis Drug Market: https://www.omrglobal.com/request-sample/dermatomyositis-drug-market

Some major players in the market include Pfizer Inc., Eli Lilly and Company, and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2021, Octapharma Group announced the approval of Octagam 10% from the US FDA. Octagam 10% is an immune globulin intravenous liquid preparation indicated for the treatment of dermatomyositis in adults.

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

• By Type

• By Application

Regions Covered-

• North America

• Europe

• Asia-Pacific

• Rest of the World

Competitive Landscape- Pfizer Inc., Eli Lilly and Company, and Novartis International AG, among others.

(Get 15% Discount on Buying this Report)

A full Report of Dermatomyositis Drug Market is Available @ https://www.omrglobal.com/industry-reports/dermatomyositis-drug-market

Global Dermatomyositis Drug Market Report by Segment

By Type

• Abatacept

• Baricitinib

• Dalazatide

• Immune Globulin

• IMO-8400

By Application

• Hospital

• Clinic

• Others

Global Dermatomyositis Drug Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermatomyositis Drug Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027 here

News-ID: 2574911 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Dermatomyositis

Dermatomyositis market expected to reach USD 1.2 billion by 2034
Dermatomyositis is a rare, chronic autoimmune condition characterized by muscle inflammation and distinctive skin rashes. The disease impacts both adults and children, with complications that include interstitial lung disease and increased cancer risk. Despite its rarity, dermatomyositis places a significant burden on patients due to disability, reduced quality of life, and high treatment costs. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71381 In recent years, the dermatomyositis market has seen
Dermatomyositis Market to Witness Promising Upswing by 2034, DelveInsight Foreca …
DelveInsight's "Dermatomyositis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Dermatomyositis, historical and forecasted epidemiology as well as the Dermatomyositis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Dermatomyositis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Dermatomyositis Market Forecast https://www.delveinsight.com/sample-request/dermatomyositis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key facts of the Dermatomyositis
Dermatomyositis (DM) Market Emerging Trends and Growth Prospects 2034
Introduction Dermatomyositis (DM) is a rare, chronic autoimmune inflammatory myopathy characterized by muscle weakness and distinctive skin rashes. It affects both adults and children and is associated with complications such as interstitial lung disease, malignancies, and cardiovascular involvement. The disease significantly reduces patient quality of life and requires long-term medical care. Historically treated with corticosteroids and immunosuppressants, the market is now evolving with biologics, monoclonal antibodies, and targeted immunotherapies. Increasing global awareness
Dermatomyositis Treatment Market Growth Accelerates: Strategic Forecast Predicts …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Dermatomyositis Treatment Industry Market Size Be by 2025? The market for dermatomyositis treatment has seen significant expansion in the past few years. It is projected to escalate from $0.85 billion in 2024 to $0.91 billion in 2025, representing a compound annual growth rate (CAGR) of 7.2%.
Dermatomyositis Market - Defying the challenges of dermatomyositis: choose our t …
Newark, New Castle, USA: The "Dermatomyositis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Dermatomyositis Market: https://www.growthplusreports.com/report/dermatomyositis-market/8675 This latest report researches the industry structure, sales, revenue, price and
Dermatomyositis Market Size, Analysis, Share, Research, Business Growth and Fore …
Dermatomyositis Market 2021 by Technology, Manufacturers, Regions, Type, and Application, Forecast guide to light the excellent analysis on the market synopsis. The report offers a primary focus on important factors in the global Dermatomyositis industry. The report includes perceptive information about gross revenue, cost, value, capacity, pricing, and profit margins concerning historical analysis and forecast estimation for the 2021 to 2031 time period. It presents a close overview of the